Nutex Health (NASDAQ:NUTX) Shares Gap Up – Here’s Why

Nutex Health Inc. (NASDAQ:NUTX) shares gapped up prior to trading on Thursday . The stock had previously closed at $122.29, but opened at $127.50. Nutex Health shares last traded at $118.99, with a volume of 93,844 shares.

Wall Street Analysts Forecast Growth

Several equities research analysts recently weighed in on NUTX shares. Maxim Group lifted their price objective on Nutex Health from $100.00 to $225.00 and gave the stock a “buy” rating in a report on Tuesday, May 20th. Wall Street Zen lowered Nutex Health from a “strong-buy” rating to a “buy” rating in a report on Thursday, May 22nd. Finally, Benchmark lifted their target price on Nutex Health from $150.00 to $300.00 and gave the company a “buy” rating in a report on Thursday, May 15th.

Nutex Health Stock Down 2.4%

The company has a current ratio of 2.27, a quick ratio of 2.26 and a debt-to-equity ratio of 1.02. The firm has a market cap of $663.86 million, a PE ratio of 10.04 and a beta of -0.04. The stock has a fifty day simple moving average of $134.51 and a two-hundred day simple moving average of $86.38.

Nutex Health (NASDAQ:NUTX) last posted its earnings results on Tuesday, May 13th. The company reported $2.56 earnings per share for the quarter, beating analysts’ consensus estimates of ($0.15) by $2.71. The business had revenue of $211.79 million during the quarter, compared to analyst estimates of $81.09 million. Nutex Health had a return on equity of 42.08% and a net margin of 10.76%.

Insider Activity

In other Nutex Health news, CFO Jon Christian Bates purchased 1,000 shares of the company’s stock in a transaction dated Tuesday, April 8th. The stock was purchased at an average price of $81.81 per share, for a total transaction of $81,810.00. Following the transaction, the chief financial officer owned 4,888 shares in the company, valued at $399,887.28. The trade was a 25.72% increase in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Company insiders own 36.92% of the company’s stock.

Institutional Trading of Nutex Health

A number of large investors have recently modified their holdings of the business. Topline Capital Management LLC bought a new stake in shares of Nutex Health during the 4th quarter valued at about $5,690,000. Essex Investment Management Co. LLC lifted its position in Nutex Health by 45.4% in the 4th quarter. Essex Investment Management Co. LLC now owns 105,809 shares of the company’s stock worth $3,353,000 after buying an additional 33,024 shares during the last quarter. American Century Companies Inc. lifted its position in Nutex Health by 73.0% in the 1st quarter. American Century Companies Inc. now owns 74,359 shares of the company’s stock worth $3,497,000 after buying an additional 31,366 shares during the last quarter. Ancora Advisors LLC bought a new stake in Nutex Health in the 4th quarter worth approximately $1,334,000. Finally, Geode Capital Management LLC lifted its position in Nutex Health by 12.6% in the 4th quarter. Geode Capital Management LLC now owns 34,125 shares of the company’s stock worth $1,082,000 after buying an additional 3,826 shares during the last quarter. Institutional investors own 5.32% of the company’s stock.

About Nutex Health

Nutex Health Inc operates as a physician-led, healthcare services, and operations company. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. The PHM segment establishes and operates independent physician associations; and offers a cloud-based platform for healthcare organizations to provide value-based care and population health management.